Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.31B P/E - EPS this Y 47.50% Ern Qtrly Grth -
Income -208.58M Forward P/E -12.87 EPS next Y 40.30% 50D Avg Chg -9.00%
Sales 355.4M PEG -0.19 EPS past 5Y - 200D Avg Chg -27.00%
Dividend N/A Price/Book N/A EPS next 5Y 44.80% 52W High Chg -55.00%
Recommedations 2.00 Quick Ratio 3.31 Shares Outstanding 206.38M 52W Low Chg 3.00%
Insider Own 1.04% ROA -10.85% Shares Float 191.43M Beta 1.96
Inst Own 88.54% ROE - Shares Shorted/Prior 33.64M/32.25M Price 6.95
Gross Margin 39.44% Profit Margin -58.69% Avg. Volume 2,556,691 Target Price 14.00
Oper. Margin -15.62% Earnings Date Aug 1 Volume 5,164,701 Change -0.29%
About BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX10013, an oral factor D inhibitor for complement-mediated diseases. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.

BioCryst Pharmaceuticals, Inc. News
05/13/24 ORLADEYO® (berotralstat) Approved in Mexico
05/09/24 BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization Among Patients with HAE Following Initiation of ORLADEYO® (berotralstat)
05/09/24 Analysts Are Updating Their BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Estimates After Its First-Quarter Results
05/07/24 BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2024 Earnings Call Transcript
05/07/24 BioCryst to Present at Upcoming Investor Conferences
05/07/24 BioCryst Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
05/07/24 BioCryst Pharmaceuticals Inc (BCRX) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
05/07/24 Q1 2024 BioCryst Pharmaceuticals Inc Earnings Call
05/06/24 Why BioCryst Pharmaceuticals Vaulted Nearly 20% Higher on Monday
05/06/24 BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance
05/06/24 BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings Call Transcript
05/06/24 BioCryst Pharmaceuticals Reports Strong Q1 2024 Results, Exceeding Analyst Revenue Forecasts
05/06/24 BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Tops Revenue Estimates
05/06/24 BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update
05/03/24 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/30/24 Will Heron Therapeutics (HRTX) Report Negative Earnings Next Week? What You Should Know
04/29/24 BioCryst Pharmaceuticals (BCRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
04/22/24 With 80% ownership, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) boasts of strong institutional backing
04/22/24 BioCryst to Report First Quarter 2024 Financial Results on May 6
04/17/24 BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency
BCRX Chatroom

User Image smnorgy Posted - 4 hours ago

$BCRX. So, anyways Guys. I think we have finally reentered the environment of SleujTheGreat. Remember?

User Image fergus0123 Posted - 6 hours ago

$BCRX BioCryst Pharmaceuticals

User Image Hero2Zero Posted - 6 hours ago

$TGTX $ARDX $BCRX $IBRX

User Image _L_F_G_ Posted - 8 hours ago

$BCRX hotdog. Bottoms in

User Image Sarge430 Posted - 10 hours ago

$BCRX What the fuck imagine 500 million shares traded on BCRX where would they put our stock price?

User Image Sarge430 Posted - 11 hours ago

$BCRX Bullshit MeMe stocks explode and we sit here with no Short Squeeze. WTF

User Image field_medic Posted - 11 hours ago

$BCRX What I miss?

User Image Noto_SoFi_Goat Posted - 11 hours ago

$BCRX Nice day for BCRX.

User Image fergus0123 Posted - 12 hours ago

$BCRX

User Image tylax30 Posted - 12 hours ago

$BCRX we breaking this $5.80 resistance today or nah? Pretty damn sure the bottom is in.

User Image BillsBowTie Posted - 12 hours ago

$BCRX My only thought on today's price action is the C-suite gave their moms shares over the weekend and don't want to make her upset. The hand that rocks the cradle is the hand that rules the world.

User Image Project_Profit Posted - 13 hours ago

$BCRX cut your losses you fools. Shorting is futile

User Image clownmarket Posted - 13 hours ago

$BCRX Listening to the JMP cc I don't hear anything new, but the vibes are positive, as expected There's a fun question from the analyst on "how can you give us such exact guidance for Q2 (97m)". Doyle explains and then reiterates they're very confident in the 97m

User Image VulcanDevilWhale Posted - 14 hours ago

$BCRX Thanks for reminding me 😂🤙🏽

User Image fergus0123 Posted - 14 hours ago

$BCRX Another L from this guy.

User Image VulcanDevilWhale Posted - 14 hours ago

$BCRX Good Morning BCRX 🖖🏽

User Image MattressMonkey007 Posted - 15 hours ago

$BCRX .... Putting out a little bowl of milk for Roaring Kitty tonight.

User Image BillsBowTie Posted - 15 hours ago

$BCRX JMP CC today 12:30EDT if you want something to do in 20 minutes... https://wsw.com/webcast/jmp63/register.aspx?conf=jmp63&page=bcrx&url=https://wsw.com/webcast/jmp63/bcrx/1678320

User Image Iwillbuy Posted - 16 hours ago

$BCRX fuck those that control this one now! Fuuccckk Stonehouse for getting his investors in this situation in the first place! He should have been tried for insider trading in my opinion! “I have no concerns” Said the liars….

User Image milt0n Posted - 16 hours ago

$BCRX Orladeyo is currently the most commonly used long-term prophylaxis treatment for adolescents. Once the pediatric formulation is approved that will add even more patients, capturing all age groups. https://www.kalvista.com/wp-content/uploads/2024/02/WSAAI_2004_BOT_US_Adults_vs_adolescents-Poster-1-29-24-Final.pdf

User Image rconnersom685 Posted - 16 hours ago

$BCRX alright added back 250,000 shares with 5.42 avg Friday and today. Holding up better than I thought. Gap fill at 445 not likely now.

User Image Andi77 Posted - 17 hours ago

$BCRX The price is being artificially held back, in my opinion. FY Short. Xbi is up 2,7%.

User Image Rmeat26 Posted - 17 hours ago

$BCRX Look how many biotechs are on this list……

User Image Biksi Posted - 17 hours ago

$BCRX ¡Vamos!

User Image Mercator_Constantine Posted - 18 hours ago

$BCRX glad to see another huge market added to our ex-US list. 20% of total revenues seems pretty conservative, although I suppose BCRX hasn’t disclosed the percentage of revenues they receive from their partners. There should be 2500 people or so with HAE in Mexico. The lat-am markets are very large. Maybe eventually we’ll get a regional revenue breakdown

User Image Biotechie60 Posted - 18 hours ago

$BCRX https://ir.biocryst.com/news-releases/news-release-details/orladeyor-berotralstat-approved-mexico

User Image Sedocan Posted - 18 hours ago

$BCRX whatever you say, regardless of the price action, the management is executing well...

User Image DontBanMeAgain Posted - 18 hours ago

$BCRX Pint needs to get selling. On the quotron it looks like:

User Image Andi77 Posted - 18 hours ago

$BCRX Damn it, go to $7. I want out of here and you can have my shares. Fucking SHORTS.

User Image Dpst2022 Posted - 18 hours ago

$BCRX Our proven discovery engine that to date has churned out one successful blockbuster drug and 4000 failures. It's only a matter of time until we repeat the process over and over again until we get another blockbuster drug from our proven discovery engine. Ask yourself what is the value in that?

Analyst Ratings
JMP Securities Market Outperform May 7, 24
HC Wainwright & Co. Buy May 7, 24
Needham Buy May 7, 24
Needham Buy Apr 10, 24
Needham Buy Jan 8, 24
Needham Buy Nov 6, 23
RBC Capital Outperform Sep 25, 23
RBC Capital Outperform Sep 18, 23
RBC Capital Sector Perform Aug 4, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Stonehouse Jon P President & CEO President & CEO Feb 01 Sell 10.38 100,000 1,038,000 1,008,739 02/02/23
Stonehouse Jon P President & CEO President & CEO Feb 01 Option 5.45 100,000 545,000 1,108,739 02/02/23
LEE KENNETH B JR Director Director Jan 31 Option 1.71 15,000 25,650 52,118 02/02/23
Sheridan William P Chief Medical Office.. Chief Medical Officer Mar 10 Option 3.22 148,302 477,532 199,093 03/14/22
Sheridan William P Chief Medical Office.. Chief Medical Officer Mar 10 Sell 17.26 161,139 2,781,259 37,954 03/14/22
Jones Michael L Exec. Director, Fina.. Exec. Director, Finance - PAO Mar 01 Option 4.73 2,300 10,879 13,498 03/03/22
Jones Michael L Exec. Director, Fina.. Exec. Director, Finance - PAO Mar 01 Sell 17.2 2,300 39,560 11,198 03/03/22
Stonehouse Jon P President & CEO President & CEO Jan 11 Option 4.73 184,000 870,320 1,085,602 01/13/22
Stonehouse Jon P President & CEO President & CEO Jan 11 Sell 15.04 184,000 2,767,360 901,602 01/13/22
Sheridan William P Chief Medical Office.. Chief Medical Officer Jun 01 Option 5.26 163,573 860,394 106,289 06/01/21
Sheridan William P Chief Medical Office.. Chief Medical Officer Jun 01 Sell 15.01 163,573 2,455,231 14,475 06/01/21
Barnes Alane P Senior VP, Chief Leg.. Senior VP, Chief Legal Officer Dec 15 Option 4.15 13,741 57,025 121,802 12/15/20